2022 · pending · MX2025006351A
Treatment of MTRES1 Related Diseases and Disorders
Gregory McInnes
Compositions comprising oligonucleotides (siRNA or ASO) that target MTRES1 for treating conditions associated with MTRES1 gene mutations.
RNA Therapeutics